Navigation Links
Fingerprints May Vanish With Cancer Drug
Date:5/27/2009

Travelers are warned of side effect that could hamper immigration checks

WEDNESDAY, May 27 (HealthDay News) -- The widely used cancer drug capecitabine can cause people to lose their fingerprints, which could lead to problems when they're trying to enter the United States, an oncologist warns.

Dr. Eng-Huat Tan, a senior consultant in medical oncology at the National Cancer Centre in Singapore, said he now advises people taking capecitabine to carry a doctor's letter when traveling.

In a letter published online Wednesday in the Annals of Oncology, Tan described the experience of a 62-year-old cancer patient taking capecitabine who was held for four hours by U.S. immigration officials because his fingerprints had vanished. The man was eventually allowed into the country.

Tan said that several other cancer patients have reported the loss of fingerprints on their blog sites and some have also said they've had problems entering the United States.

Capecitabine -- used to treat head and neck cancers, breast, stomach and colorectal cancers, among others -- can cause a side effect called hand-foot syndrome. This is a chronic inflammation of the palms of the hands or soles of the feet that can cause the skin to peel, bleed and develop ulcers or blisters, Tan said.

"This can give rise to eradication of fingerprints with time," he explained.

"In summary, patients taking long-term capecitabine may have problems with regards to fingerprint identification when they enter the United States' ports or other countries that require fingerprint identification and should be warned about this," Tan wrote.

"It is uncertain when the onset of fingerprint loss will take place in susceptible patients who are taking capecitabine," Tan said. "However, it is possible that there may be a growing number of such patients as 'Mr. S.' who may benefit from maintenance capecitabine for disseminated malignancy. These patients should prepare adequately before traveling to avert the inconvenience that 'Mr. S.' was put through."

Tan recommended that people taking capecitabine carry a letter from their oncologist.

"My patient subsequently traveled again with a letter from us, and he had fewer problems getting through" immigration, Tan said.

More information

The U.S. National Library of Medicine has more about capecitabine.



-- Robert Preidt



SOURCE: Annals of Oncology, news release, May 27, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Cancer drug causes patient to lose fingerprints and be detained by US immigration
2. DNA Fingerprints Predict Brain Disorders
3. Stand Up to Cancer awards $73.6 million for novel, groundbreaking cancer research
4. Berkeley Lab scientist co-leads breast cancer dream team
5. $18 million awarded to TGen and University of Pennsylvania for pancreatic cancer research
6. New Survey Highlights Growing Concern About Risk of Infection in Cancer Patients and Emerging Antibiotic Resistance
7. Gene Mutation May Up Risks of Endometrial Cancer
8. U.S. Cancer Death Rates Continue to Fall
9. Hanes(R) Teams up with Susan G. Komen for the Cure(R) and Actress Sarah Chalke to Comfort Those Affected by Breast Cancer
10. Predicting higher risk for prostate cancer diagnosis
11. Risks Remain for Childhood Cancer Survivors
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Fingerprints May Vanish With Cancer Drug
(Date:6/26/2016)... (PRWEB) , ... June 26, 2016 , ... On June ... sponsor of the 2016 Cereal Festival and World’s Longest Breakfast Table in Battle Creek, ... of the city’s history as home to some of the world’s leading providers of ...
(Date:6/25/2016)... D.C. (PRWEB) , ... June 25, 2016 , ... ... discuss health policy issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, ... their work on several important health care topics including advance care planning, healthcare ...
(Date:6/25/2016)... , ... June 25, 2016 , ... As a lifelong ... Cum Laude and his M.D from the David Geffen School of Medicine at UCLA. ... to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai ...
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced traumatic events may suffer ... unhealthy avenues, such as drug or alcohol abuse, as a coping mechanism. To avoid ... healthy coping following a traumatic event. , Trauma sufferers tend to feel a range ...
(Date:6/24/2016)... San Francisco, CA (PRWEB) , ... June 24, ... ... at CitiDent, is now offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has ... , self-ligating Damon brackets , AcceleDent, and accelerated osteogenic orthodontics. , ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... , June 23, 2016 Research ... Devices Global Market - Forecast to 2022" report to ... the treatment method for the patients with kidney failure, it ... excess fluid from the patient,s blood and thus the treatment ... potassium and chloride in balance. Increasing number ...
(Date:6/23/2016)... Roche (SIX: RO, ROG; OTCQX: RHHBY) announced ... BRAHMS PCT (procalcitonin) assay as a dedicated testing solution ... this clearance, Roche is the first IVD company in ... sepsis risk assessment and management. PCT is ... levels in blood can aid clinicians in assessing the ...
(Date:6/23/2016)... , June 23, 2016 Bracket , a ... its next generation clinical outcomes platform, Bracket eCOA (SM) ... on June 26 – 30, 2016 in Philadelphia ... electronic Clinical Outcome Assessment product of its kind to fully ... Bracket eCOA 6.0 is a flexible platform for ...
Breaking Medicine Technology: